S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note
ST Pharm Co Ltd
/
Income Statement
/
Revenue

ST Pharm Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Revenue
₩278.6B
CAGR 3-Years
20%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Revenue
₩4.2T
CAGR 3-Years
47%
CAGR 5-Years
54%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Revenue
₩52.8B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Revenue
₩14.9B
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Revenue
₩101.4B
CAGR 3-Years
36%
CAGR 5-Years
15%
CAGR 10-Years
57%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Revenue
₩22.7B
CAGR 3-Years
268%
CAGR 5-Years
56%
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is ST Pharm Co Ltd's Revenue?
Revenue
278.6B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Revenue amounts to 278.6B KRW.

What is ST Pharm Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
30%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for ST Pharm Co Ltd have been 20% over the past three years , 30% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.